文献速递创伤骨科骨质疏松与代谢性骨病

心血管疾病史和心血管生物标志物与髋部骨折患者30天死亡率相关

History of cardiovascular disease and cardiovascular biomarkers are associated with 30-day mortality in patients with hip fracture.
PubMed 文献 · Osteoporos Int · 2019-07-04

该研究基于丹麦国家患者登记系统,纳入113,211例髋部骨折患者,发现既存心力衰竭、缺血性心脏病和缺血性卒中与30天死亡率升高相关;在355例亚组中,NT-proBNP每升高一个四分位数和HDL胆固醇每降低一个四分位数与30天死亡率相关。

要点

  • 既存心血管疾病与髋部骨折后30天死亡率升高相关。
  • NT-proBNP升高和HDL胆固醇降低与30天死亡率增加相关。
  • 基于生物标志物的模型可用于识别高风险患者。

核心结论

  • 既存心血管疾病与髋部骨折后30天死亡率升高相关。
  • 高NT-proBNP水平和低HDL胆固醇水平与30天死亡率升高相关。

研究设计与样本

  • 全国性基于人群的队列研究,使用丹麦国家患者登记系统,纳入113,211例患者。
  • 亚组分析纳入355例有本地生物库血样的患者,分析生化标志物与死亡率的关系。
  • 主要结局为30天死亡率。

主要发现

  • 总队列中,心力衰竭占9.4%,缺血性心脏病占15.9%,缺血性卒中占12.0%。
  • 30天内11,488例患者死亡,总体30天死亡率为10.1%。
  • 既存心力衰竭的30天死亡率多变量校正比值比为1.69(95%置信区间1.60-1.78),缺血性心脏病为1.23(1.17-1.29),缺血性卒中为1.06(1.00-1.12)。
  • 本地数据库355例患者中,41例(11.5%)在30天内死亡。
  • 30天死亡率的多变量校正比值比随NT-proBNP每升高一个四分位数而增加(2.36 [1.53-3.64]),随HDL胆固醇每升高一个四分位数而降低(0.58 [0.41-0.82])。

关键数值与推荐

  • 既存心力衰竭:多变量校正比值比1.69(95%置信区间1.60-1.78)。
  • 既存缺血性心脏病:多变量校正比值比1.23(95%置信区间1.17-1.29)。
  • 既存缺血性卒中:多变量校正比值比1.06(95%置信区间1.00-1.12)。
  • NT-proBNP每升高一个四分位数:多变量校正比值比2.36(95%置信区间1.53-3.64)。
  • HDL胆固醇每升高一个四分位数:多变量校正比值比0.58(95%置信区间0.41-0.82)。

临床怎么用

  • 这些发现可用于识别可能从专门护理中获益的高风险患者。
  • 基于生化标志物建立了预测死亡概率的模型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Hip fractures are associated with increased mortality and it is important to identify risk factors. This study demonstrates that preexisting cardiovascular disease as well as cardiovascular biomarkers that are associated with increased 30-day mortality. These findings can be used to identify high-risk patients who might benefit from specialized care. INTRODUCTION: This study investigates the association between cardiovascular disease (CVD), cardiovascular biomarkers, and 30-day mortality following a hip fracture. METHODS: The Danish National Patient Registry was used to investigate the association between CVD and mortality following hip fracture in a nationwide population-based cohort study. In a subset of the included patients (n = 355), blood samples were available from a local biobank. These samples were used for analyzing the association between specific biochemical markers and mortality. The primary outcome was 30-day mortality. RESULTS: A total of 113,211 patients were included in the population-based cohort study. Among these, heart failure was present in 9.4%, ischemic heart disease in 15.9%, and ischemic stroke in 12.0%. Within 30 days after the hip fracture, 11,488 patients died, resulting in an overall 30-day mortality of 10.1%. The 30-day mortality was significantly increased in individuals with preexisting CVD with multivariably adjusted odds ratios of 1.69 (95% confidence interval, 1.60-1.78) for heart failure, 1.23 (1.17-1.29) for ischemic heart disease, and 1.06 (1.00-1.12) for ischemic stroke. In the local database including 355 patients, 41 (11.5%) died within 30 days. The multivariably adjusted odds ratio for 30-day mortality increased with increasing NT-proBNP (2.36 [1.53-3.64] per quartile) and decreased with increasing HDL cholesterol (0.58 [0.41-0.82] per quartile). On this basis, we established a model for predicting the probability of death based on the biochemical markers. CONCLUSION: Preexisting CVD was associated with increased 30-day mortality after a hip fracture. Furthermore, high levels of NT-proBNP and low levels of HDL cholesterol were associated with increased 30-day mortality.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Norring-Agerskov D, Madsen CM, Bathum L, et al. History of cardiovascular disease and cardiovascular biomarkers are associated with 30-day mortality in patients with hip fracture. Osteoporos Int. 2019. PMID: 31278472. doi:10.1007/s00198-019-05056-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。